Emily is dying. So why is she selling off her remaining time to strangers?

This 32-year-old Australian has terminal cancer, but she has taken part in a daring, moving public project to raise money for research – and encourage us to consider how we live.

It’s sunny on Saturday morning when I enter Carriageworks in the Sydney suburb of Eveleigh, and the farmers market is in full throttle outside. But I bypass the stalls and crowds: I’m here to spend some time with a young woman named Emily Lahey. Three minutes, to be precise.

Entering the darkness of one of the venue’s concrete performance bays, I sit on a spotlit bench and watch a brief video narrated by Emily. Then she joins me, and we sit side by side as a massive digital clock projected on to the wall in front of us counts down from 3:00 to 0:00. When my time is up, I must leave.

Over the course of the day, about 30 people sat with Emily. Some used their three minutes for quiet reflection. Others wanted conversation, asking her questions or sharing why they had come to see her. Usually you’d describe a project like this as performance art, but Emily isn’t an artist: she’s a terminally ill 32-year-old who doesn’t know how much time she has left. Her performance is part of a project titled Time to Live, designed by the Australian Cancer Research Foundation (ACRF) to raise awareness and funds. Each participant has effectively “bought” a slice of Emily’s time. Some were complete strangers, others were family and friends; either way, the experience provoked strong emotions. In the foyer afterwards, I meet another participant, Helen, who is visibly moved. It has raised a lot of both of us: we speak about the grief of losing our mums to cancer, the anxiety of living with a genetic predisposition.

Meeting Emily for the first time, you wouldn’t know she was sick, let alone that she had undergone successive rounds of chemo, radiotherapy and immunotherapy. “People don’t believe it when I tell them that I have terminal cancer,” she says when we talk over Zoom a few days ahead of her performance.

In 2019, when she was just 27, doctors discovered a tumour the size of a cricket ball in her sinus and skull bone. Just a few months earlier she’d felt healthy and fit, and was running 5-10km a day, as a member of the Australian defence force. When she developed headaches and symptoms consistent with sinusitis, doctors initially dismissed it as such, and it was only when she began to lose vision in her left eye that scans revealed the tumour. Chemotherapy proved unsuccessful; the cancer had metastasised. Genomic testing revealed it was NUT carcinoma, a rare and aggressive mutation with few treatment options and a typical prognosis of six to nine months.

That Emily is still alive four years later is in large part due to a cutting edge treatment that is not yet available in Australia, that she was able to access from the US as part of a “compassionate” government scheme – but only once her condition had deteriorated sufficiently, and the more common treatments had proven ineffective. “[At the time] knowing that there was a proven treatment option with demonstrated efficacy overseas was really frustrating. I was like, ‘Why can’t I access it now?’” Emily says.

This aspect of Emily’s experience embodies the raison d’etre of ACRF, “to fund world-class research into the prevention, diagnosis and treatment of [cancer]”. Founded in 1984, the charity has distributed more than $184m to research institutions across Australia – and ahead of its 40th anniversary, it engaged David Gibson and Nathan Lennon, former creative directors at New York ad agency Droga5 (and best known in Sydney as co-founders of Hawke’s Brewing in Marrickville) to devise a campaign calling attention to the life-changing potential of its work.

It was Gibson and Lennon who came up with the idea of Time to Live, working with ACRF’s fundraising and marketing manager, Carly du Toit, who found Emily via a call-out. “She embodies everything that ACRF does. She is brave and bold,” Du Toit says. “And she truly is a collaborator on the project. It’s not just us bringing her on board and telling her story. She’s actively contributed to all components of the exhibition and the experience.”

Taking part was “a no-brainer” for Emily. “Without research, I wouldn’t be here,” she says. “The treatments that I’m on and the testing that I’ve been through to allow access to those treatments, are quite advanced.” She hopes Time to Live shows “the importance of continued funding towards those research efforts, to give people like me more time.”

The video I watch before sitting with Emily reveals what that extra time has meant for her. You get to see her celebrating big milestones such as her 30th birthday and her wedding to her partner, Jason, who she met just three weeks before her cancer diagnosis. You also see smaller moments, the daily joy and laughter of time spent with family and friends. In her narration, she describes her remaining time as “not a clock running out, but a precious gift not to be wasted”.

As a participant, this message hits home: inevitably, you evaluate your own life against this metric. Am I making the most of it? Helen says that this was one of the reasons she took part. She has had personal experience with cancer: every woman in her family has had it, and she lost her mum to it five years ago. “I need something that’s going to kick me into living, kick me into doing something,” she tells me. “I’m 55. Is it too late?”

Standing in the queue we bypass the chit-chat and go straight to the big topics; the experience has made us emotional and philosophical, and we end up having the kind of conversation that’s rare even among friends. We talk about how considering Emily’s story, and preparing to spend time with her, has had a kind of emotional and psychological ripple effect. Beyond the funds raised, and the time spent in the room, this is perhaps the enduring impact: a rare moment to grapple with the fleeting nature of life, and to connect with others in that grappling.

As each of us leaves Time to Live, Emily hands over an envelope with a card inside; it reads: “I’ve given you my time. Now it’s your time to give that gift to someone else.”

This article was originally published by The Guardian. You can read the original article here.

Australian Cancer Research Foundation Celebrates 40 Years of Backing Brilliant Cancer Research

Australian Cancer Research Foundation (ACRF) is celebrating its milestone 40th anniversary of backing bold, brave and brilliant cancer research. Since 1984, ACRF has awarded 86 grants totalling over $184 million to 44 Australian research institutions pursuing new and improved ways to prevent, detect and treat all types of cancer.  

ACRF funding has provided researchers with cutting-edge equipment and technology that has led to groundbreaking world-first discoveries. Some of the most notable include: 

  • The development of the HPV Cervical Cancer Vaccine 
    ACRF gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV) vaccine. Over 150 million doses of the vaccine have since been delivered worldwide.  

  • Foundational support for the national ZERO Childhood Cancer Program 
    Zero Childhood Cancer is the most comprehensive precision medicine program for children and young people with cancer in the world. ACRF has proudly supported Children’s Cancer Insititute with almost $11million to progress many of their innovations that fuel this program.  

  • The discovery of new breast cancer genes 
    ACRF has provided three grants, totalling $8.4 million to QIMR Berghofer Medical Research Institute which led to a team of researchers discovering at least 12 new genes that influence the risk of developing breast cancer. 

  • A blood test that detects early stages of cancer 
    ACRF provided $5.5 million in funding to The Walter and Eliza Hall Institute where researchers developed a blood test that can detect the presence of eight common cancers. The test has been shown to reliably detect early-stage and curable cancers. 

Whilst significant progress has been made over the past 40 years, cancer is still a leading cause of death in Australia. 444 Australians are diagnosed with cancer every day, and 135 lives are lost from this devasting disease each day. ACRF’s mission is to support the very best scientific research across all types of cancers, including rare cancers.  

Carly Du Toit, GM Fundraising and Marketing, said ACRF’s work is far from over. 

“For 40 years, ACRF has been funding bold and innovative cancer research, which has resulted in lifesaving scientific breakthroughs. But our work is far from done. Until survival rates from cancer are closer to 100%, we have more work to fund, more research to back,” Carly said. 

To mark this significant milestone, ACRF is launching a first-of-its-kind living art exhibition, entitled ‘Time to Live: A Terminal Exhibition’. A woman named Emily Lahey living with terminal cancer will be auctioning off minutes of her precious remaining time to strangers. The hope is the idea can get people to understand the importance of research, not as a technical and scientific thing, but more as an opportunity and gateway for us to get more time with those we love by stopping cancer in its tracks. 

Emily Lahey was diagnosed with NUT Carcinoma, a rare, aggressive cancer with an average prognosis of just six to nine months. As visitors of Time to Live spend time with Emily, an imposing projection of a timer will count down from three minutes. This profound and fleeting encounter offers a unique opportunity to grasp the emotional and psychological weight of living with or being connected to someone with a terminal diagnosis. 

Aussie Woman Auctioning Off Her Final Moments For Cancer Research

Emily Lahey is just 32, but she is already planning for her time to be her final gift to the world. Diagnosed with cancer, she’s auctioning off her final minutes to raise money for cancer research.

Watch Emily Lahey and Australian Cancer Research Foundation on The Project:

Dying woman Emily Lahey auctions off her final minutes for cancer research

Emily Lahey is dying and doesn’t know how much time she has left. But she’s decided to do something that no one has ever done before.

Emily Lahey is dying. She’s not sure how much time she has left on this earth – days, weeks, months or, hopefully, years – but she is determined to leave it better than she found it. And she is.

The 32-year-old is about to do something never been done before. Next month, she will host a once-in-a-lifetime living art exhibition, where she will auction off three-minute pieces of her remaining time to raise money for cancer research. Research like that which has already given Lahey three years of borrowed time, after being diagnosed with an incredibly rare and aggressive cancer in 2019, when she was told she had less than nine months to live.

In the face of a terminal illness, her powerful Time to Live: A Terminal Exhibition will allow those moved by her plight to sit with her as the clock ticks down from three minutes to zero. That’s 180 seconds. To talk about death, life and everything in between. Or to sit in silence, and reflect on fears, wishes and impending mortality.

Once your time is up, that’s it. An overwhelming reality facing us all, but it is staring Lahey in the face every day. And far too soon.

“There’s been nothing like it before,” she says of the exhibition.

“One of the key goals is to make people stop and think about the their time, and the time of the people that they love, and what they’re doing with their time and how they can make the most of that time they have.

“Anything can happen to anyone at any time.

“It’s almost a privilege to be able to see life through a different lens, as opposed to rose- coloured glasses – to be able to make the most of it.

“There’s something powerful about being able to take ownership of your life and make those decisions … a lot of people don’t have that opportunity. “People that are facing terminal illness, we see life with a different lens.”

“Both my family and I no longer take things for granted; we no longer take time together for granted.

“We just try and make the most of every day. We celebrate small wins, big wins – any excuse to celebrate something.

“Yes, it is very, very challenging – but there is an element of power in being able to maintain some level of control among a situation that you’ve got so little control over.”

Emily Lahey, 32 has NUT Carcinoma, an aggressive cancer with a prognosis of just nine months. Picture: Jason Edwards

The Tasmanian-born one-time Sydneysider now calls Melbourne home, and was like anyone else before October 2019. She was 27. Fit, healthy, driven. She was a member of the Australian Defence Force and had dreams of a long and accomplished career, buying her own home, having a family.

Then headaches and sinusitis symptoms were dismissed as such – until Lahey started losing vision from her left eye. Scans showed a cricket ball-sized mass in her sinus skull bone, and a diagnosis of NUT carcinoma, with a six-to-nine-month survival rate. About 100 people are diagnosed with the rare cancer every year. It’s hard to test for and diagnose, it doesn’t respond well to standardised treatments. There is no cure.

“Before I was diagnosed, I was otherwise fit and healthy. I was running 5 to 10km a day, was in the height of my career,” Lahey says. “I obviously had dreams and hopes and goals, like anybody that age would, and then within an instant, all of that was taken away,” she says.

“My treating oncologist had never heard of that type of cancer before, which I guess doesn’t instil a lot of confidence initially, although I have nothing but positive things to say about my treating medical team.

“It was just by chance that there was somebody on exchange from the UK or US working at The Alfred Hospital here in Melbourne at the time that had heard of it, and was able to reach back to some colleagues and we were able to get a little bit more info about it.

“What wasn’t communicated to me at the time was the prognosis and lack of treatment options available, which we unfortunately found out through a Google search, which made it even more awful.

“I remember my mum sitting next to me at the hospital, where I was being treated as an inpatient, about to start chemotherapy, and she said … ‘that’s just not you’.

“She said, ‘You are the exception’.

“And I guess, in time, I’ve proven that I am the exception.”

She’s the exception because she’s still here. After brutal – and unsuccessful – rounds of chemo, radiotherapy and immunotherapy, a potential treatment option not available in Australia was identified. Lahey was granted special access to this treatment, which has brought her three additional years of life – time she was told wasn’t possible. Genomic testing was sent to Sydney’s renowned Garvan Institute, and as a result, for the past three years Lahey has taken targeted treatment of seven tablets five days a week.

She is the longest-surviving patient using this treatment.

Recently, however, it was discovered the cancer had spread to her brain. Doctors cannot tell how long she has.

But whatever time Lahey has left, she’s making it count.

“I would say I’ve had success; it’s not a drug that can cure you or make you cancer free, but as long as things remain stable, then that’s a win,” she says.

“I’ve had some regrowth of my primary tumour in that time, and also metastasis to the brain … so I guess that falls back into my belief into cancer research, because without things like genomic testing, targeted treatments and support for people with rare cancers, I wouldn’t be here. I’m proof that it works.

“It obviously still sits very heavy on me and my loved ones … but I think there’s a part of me that has disassociated from the disease.

“I don’t look in the mirror and see somebody that, on paper, is terminally ill.

“I’ve fought hard over the last nearly five years now to live as normal life as I can.”

Emily Lahey and partner Jason Gregson. Picture: Jason Edwards
Emily Lahey and partner Jason Gregson. Picture: Jason Edwards

Three weeks before her shock diagnosis, Lahey started going out with someone new, but when she learnt what lay ahead she urged him to move on with his life.

But Jason Gregson stayed – Lahey says you would struggle to find a more positive person – and they were married in November last year. It was one of the highlights of their lives, and a future they weren’t sure they’d be blessed with.

Buying a house, which they did, was something else on Lahey’s bucket list, which she likes to call her “living list”.

“We had the most beautiful day; it was just a dream,” she says.

“A lot of people have a bucket list; I have a living list, and we’ve made it our mission to tick off as many of those things as we can.

“Some of them have been quite extravagant, whereas others have been pretty mundane.

“I’m a member of the defence force, so current serving member of the army, and it was my goal to reach the rank of sergeant by the age of 30, which I was still able to achieve.

“I purchased my first home by the age of 30. Obviously, we got married.

“There’s been some travelling, although covid ruined a lot of those plans. I wanted to swim with the whale sharks in Exmouth, which we did. I was able to stay at Saffire Freycinet (Tasmania) for my 31st birthday. I wanted to swim in the pool at the Marina Bay Sands (Singapore), which my mother and I did last year.

“Jason and I walked the three-day trek at Capes Track in southern Tasmania. I’m not gonna say it was easy, but the sense of achievement having done that was just phenomenal.

“I think we just try and make the best of every day, and I’m just so thankful for the opportunities we’ve been given that we wouldn’t have been given if it wasn’t for these advances in medical research.”

One of the hard things for Lahey is that she doesn’t look sick. She’s still able to function, and her body is getting used to what’s happening.

“It’s really challenging and I think you control what you can control, and that’s always been a priority to me,” she says.

“Even when I started to lose my hair during chemo, the decision was made that I would shave my head, because you just clutch on to those tiny little things that you can control.

“I know my family has really struggled to deal with my prognosis, and my friends as well. “There’s been lifelong friends that I’ve had and subsequently lost because they don’t know how to deal with it.

“They don’t know how to support, it’s almost ‘too-hard basket’ for them, because it makes people so uncomfortable and they just can’t deal with it.

“Because, on face value, I don’t look sick. I don’t look like I have a terminal illness, because people associate terminal illness with end of life.

“I’m not skin and bones, I have a head of hair, I go to the gym and I go to the supermarket and you wouldn’t know if you didn’t know.

“And I think that also forms part of this campaign, that this can happen to anyone. And it can be happening to anyone.

“It can be your neighbour, the person you train with at the gym, the person you will pass in the supermarket.

“So I want to create that wider awareness as to not just the impact, but also to fight societal norms of what cancer and terminal illness looks like.

Lahey says it is not a part of her life she would normally advertise.

“Like, I don’t introduce myself and say, ‘Hi, I’m Emily and I have a terminal illness’ – it’s a mood killer,” she says.

Today, like most days, Lahey feels as well as she can feel. The vision in her left eye never returned, presenting new challenges. She gets scans every three months to monitor the cancer that metastasised on her brain. She’s never out of the woods, just in the limbo of “scanxiety” that every 60 days determine her fate.

“The biggest scare or worry for me is that if and when my condition does deteriorate, there are no other treatment options available to me,” Lahey says.

“The targeted treatment that I’m on now is sort of a last resort, and I’d begin looking at clinical trials which, as of two days ago, there are none here in Australia.

“So that’s overwhelmingly the biggest anxiety. You go into those scans expecting the worst, but hoping for the best.

“I used to make a big deal out of positive results, whereas now I just breathe out and wait for the next slot.

“I’m obviously thankful that the results are positive, but it still doesn’t mean that it’s good news.”

Emily Lahey during her treatment.
Emily Lahey during her treatment.
Emily has been told she has 6-9 months to live.

Emily has been told she has 6-9 months to live.

That makes cancer research more important than ever. And through Time to Live: A Terminal Exhibition, Lahey is raising both money and awareness for the Australian Cancer Research Foundation as her last gift to the world. A gift that will one day lead to answers.

“There’s been a paper that was written up in a medical journal on my case … to provide that as a lifeline for somebody else, whether they’re in Australia or overseas,” Lahey says.

“I’m hoping that I can use my experiences to do something positive.”

Time to Live is that something, too. The interactive artwork invites the public to engage in one-on-one time with Lahey, highlighting the preciousness of time and the gravity of her life, as a projection counts down from three minutes.

The profound encounter offers a unique opportunity to grasp the emotional and psychological weight of living with, or being connected to someone with a terminal diagnosis.

Interested guests can apply online and pledge the amount they’re willing to donate for three minutes spent with Lahey.

“I feel privileged, I feel nervous, but I think if people just stop and think for a moment, that wider impact has the potential to have quite a wide reach,” she says.

“So people that participate will be shown my life story through a spoken narrative, and photos and video footage from my life, which form part of the installation, and through that narrative it’s designed to make people feel a level of discomfort, to a degree.

“Then I will sit with that person for three minutes, with the counter counting down.

“There’s no script. If people want to talk, we talk. If people want to sit in silence, we’ll sit in silence

“If people want a physical connection. we’ll create that physical connection.

“I don’t know if it’s healthy or not, but I’ve disassociated with the disease, to a degree.

“It’s not something I see when I look in the mirror, so you just sort of carry on.

“When I was first diagnosed, my mum and I had this little mantra between us, and that was ‘be present’.

“Be present in that moment, in that day.

“At that time, I lacked the ability to plan too far ahead – it was literally just that day. And then it was maybe to the end of the week, and then as time has gone, that ability to look further out has increased.

“Over time, as well, there’s been some opportunities that have presented themselves, through charities, non-profits, and within that patient advocacy space, and that’s how can I use my experiences to educate, empower and impact other people to create change, be that on an individual community or government level, for other patients with rare cancers.

“This is the largest and most impactful campaign that I’ve had the pleasure to be part of.”

Lahey has made a will and has a playlist of songs for her funeral – part of taking control of the uncontrollable. She’s even left specific gifts and experiences for family and friends, and is getting to do some of those with them now, instead of them having to do it after she’s gone.

“A lot of those friends don’t even know that those experiences were for that purpose,” Lahey says.

“Jason and I took some of our friends to the Jackalope Hotel on the Mornington Peninsula, as it was something they had always wanted to do … so we took them as a surprise one weekend and the whole experience was just phenomenal.

Emily Lahey in her living art exhibition auctioning off 3 minute pieces of her remaining time to raise money for cancer research.

Emily Lahey in her living art exhibition auctioning off 3 minute pieces of her remaining time to raise money for cancer research.

“I have changed,”Laheysays of herself post diagnosis. “I definitely find it easier to let go of things that no longer serve me.

“I’m a lot better at not getting wrapped in the small things and small inconveniences.

“This whole experience has given me a greater perspective about just life in general.

“The way in which I treat other people, in that you don’t know what other people have got going on.

“It’s that whole road rage thing: You might see people driving like a maniac, and people go nuts on the road. That person in that car may have just found out that their daughter has six months to live.

“It’s given me a greater insight as to the human condition and how important it is that we treat people with kindness.

“I think when you’re young, you think you know what your purpose is, and for me, that was a long-term career in the defence force, and probably getting married, starting a family – just life stuff. When that stuff is taken away from you, I guess you have two choices: You can remain stagnant, or you can pivot.

“How can I regain a sense of purpose? And what does that sense of purpose look like?

“For me, that is what has been.”

This article was originally published by The Daily Telegraph You can read the original article here.

Woman with terminal cancer auctions off time in Sydney living art exhibit for cancer research

‘Time is a very valuable thing … a thing cancer can take away too much of.’

“Time is for living in the present.”

It is a simple message often taken for granted, but what if you could see the minutes of your life slipping away?

Melbourne resident Emily Lahey is among the tens of thousands of Australians who face this reality. The 32-year-old lives with NUT carcinoma — a rare, aggressive cancer with an average prognosis of just six to nine months.

Lahey is auctioning pieces of her precious remaining time to strangers in Sydney this weekend as part of a living artwork, Time to Live.

As visitors spend time with Lahey, an imposing projection of a timer counts down from three minutes, ticking away their moments together.

The “once-in-a-lifetime” experience aims to spotlight the emotional and psychological weight of living with, or being connected to someone with a terminal diagnosis, as well as emphasise the importance of cancer research.

‘A constant rollercoaster’

Before her diagnosis at 27, Lahey was fit and healthy, running 5km to 10km a day. “I certainly didn’t think cancer was a possibility,” she told 7NEWS.com.au.

She struggled with prolonged sinusitis and headaches, but it was only when she started to rapidly lose vision in one of her eyes that doctors realised her common symptoms were something more sinister. Scans discovered a mass “about the size of a cricket ball” across her sinuses and skull bone.

The rare cancer does not respond well to common cancer treatments such as chemotherapy, leaving her team “unsure where to start”.

Genetic testing helped narrow Lahey’s options down to an unapproved treatment called BET inhibitors. But she had to wait for her condition to deteriorate to be deemed eligible for the government’s special access scheme to access it.

“It has allowed me extra time that I wouldn’t have thought I’d have, and that’s something both me and my family are very grateful for,” she said. While doctors do not know how long Lahey has left, she makes the most of each precious day.

“Everything comes and goes in waves. It’s like being on a constant rollercoaster,” she said. “There were times that I really struggled to even look to the following day, to the end of the week, to the next month.

“As time has gone on, it’s giving me a little bit of a little bit more confidence to be able to look out to towards the end of the year.”

Making the most of minutes

Cancer is the leading cause of death in Australia, according to the Australian Institute of Health and Welfare (AIHW). Despite this, it is something people usually think will not happen to them or their loved ones, Lahey said.

“Time is a very valuable thing,” Lahey said. “It’s a thing cancer can take away too much of.”

Lahey hopes the raw and intimate experience on Saturday will help people reassess what’s important in their lives and highlight the importance of cancer research.

In the early 1990s, Australia’s cancer survival rate was just over 50 per cent, according to the AIHW. By the late 2010s, almost 70 per cent of Australians survived for at least five years after being diagnosed.

“Until survival rates are close to 100 per cent, I think as a community we need to continue to support progressive new ideas and cancer research,” she said.

The bold art experience is an initiative by the Australian Cancer Research Foundation (ACRF), which funds innovative cancer research across all types of cancers, including rare cancers.

“There’s still a long way to go,” fundraising and marketing general manager Carly Du Toit said.

“We hope this idea helps highlight the continued need for backing brilliant research that could give those impacted by cancer, like Emily and her loved ones, the gift of the most precious thing we desire — more time.”

This article was originally published on 7news.com.au. You can read the original article here.